Pharma

Your Article Summary

See Latest Articles

Decision About European Marketing Authorization for Oracea Postponed to 2008
MediGene, 07/31/07

MediGene AG has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea has been postponed. The committee of the nine countries involved in the decentralised procedure (Coordination Group for Mutual Recognition and Decentralised Procedures, CMD) did not reach a unanimous decision, and therefore refers the procedure to another committee for decision-making

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

See All of Marketing/Media/ROI